Heron Therapeutics, Inc. HRTX
0.38 USD +0.09 (+29.42%)
Nov 9, 2026, 10:57 AM EST
0.35 Day range 0.42
0.26 52-week range 1.58
- YTD
- -70.83%
- 1 year
- -65.53%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 154.90M | 144.28M | 127.04M | 107.67M | 86.35M | |
| 113.56M | 105.64M | 61.94M | 52.80M | 40.33M | |
| -2.54M | -11.53M | -110.61M | -174.66M | -218.71M | |
| -20.20M | -13.58M | -110.56M | -182.02M | -220.68M | |
| -0.12 | -0.09 | -0.80 | -1.67 | -2.24 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 28.65M | 25.80M | 28.68M | 15.36M | 90.54M | |
| 255.88M | 233.15M | 222.51M | 250.95M | 305.71M | |
| 241.54M | 266.80M | 256.48M | 237.38M | 228.14M | |
| 140.64M | 177.76M | 179.63M | 157.48M | 159.50M | |
| 14.33M | -33.65M | -33.97M | 13.57M | 77.57M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -27.59M | -22.53M | -58.79M | -146.91M | -203.35M | |
| 16.01M | 18.71M | 18.00M | -3.32M | 32.73M | |
| 14.43M | 940.00K | 54.11M | 75.06M | 156.03M | |
| -219.00K | -1.68M | -1.53M | -1.60M | -2.99M | |
| 2.85M | -2.88M | 13.31M | -75.18M | -14.60M |